Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (51-60 of 753) with videos related to

Pageof 76
Sort By:
Statistics in Medicine|April 1, 1987
Interpretation of results from subset analyses within overviews of randomized clinical trialsR D Gelber, A Goldhirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancerR D Gelber, A Goldhirsch
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
From the overview to the patient: how to interpret meta-analysis dataR D Gelber, A Goldhirsch
Archives of Gynecology and Obstetrics|January 1, 1995
-Adjuvant systemic therapy of breast carcinoma-A Goldhirsch, M Castiglione-Gertsch
Oncology (Williston Park, N.Y.)|May 15, 2010
Adjuvant endocrine therapy in premenopausal women with operable breast cancer: understanding the issuesAron Goldhirsch, Karen N Price
Journal of the National Cancer Institute|August 17, 1988
Can a clinical trial be the treatment of choice for patients with cancer?R D Gelber, A Goldhirsch
Nature Reviews. Clinical Oncology|September 6, 2012
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacyAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|November 27, 2004
Life with consequences of breast cancer: pregnancy during and after endocrine therapiesAron Goldhirsch, Richard D Gelber
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
Reply to: prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancerA Goldhirsch, A S Coates
The New England Journal of Medicine|May 5, 1994
Understanding adjuvant chemotherapy for breast cancerA Goldhirsch, R D Gelber
Pageof 76

Showing results (51-60 of 753) with videos related to

Sort By:
Pageof 76
Statistics in Medicine|April 1, 1987
Interpretation of results from subset analyses within overviews of randomized clinical trialsR D Gelber, A Goldhirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancerR D Gelber, A Goldhirsch
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
From the overview to the patient: how to interpret meta-analysis dataR D Gelber, A Goldhirsch
Archives of Gynecology and Obstetrics|January 1, 1995
-Adjuvant systemic therapy of breast carcinoma-A Goldhirsch, M Castiglione-Gertsch
Oncology (Williston Park, N.Y.)|May 15, 2010
Adjuvant endocrine therapy in premenopausal women with operable breast cancer: understanding the issuesAron Goldhirsch, Karen N Price
Journal of the National Cancer Institute|August 17, 1988
Can a clinical trial be the treatment of choice for patients with cancer?R D Gelber, A Goldhirsch
Nature Reviews. Clinical Oncology|September 6, 2012
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacyAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|November 27, 2004
Life with consequences of breast cancer: pregnancy during and after endocrine therapiesAron Goldhirsch, Richard D Gelber
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
Reply to: prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancerA Goldhirsch, A S Coates
The New England Journal of Medicine|May 5, 1994
Understanding adjuvant chemotherapy for breast cancerA Goldhirsch, R D Gelber
Pageof 76